Dilip Panjwani

880 total citations
19 papers, 630 citations indexed

About

Dilip Panjwani is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Hematology. According to data from OpenAlex, Dilip Panjwani has authored 19 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiation and 4 papers in Hematology. Recurrent topics in Dilip Panjwani's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Radiotherapy Techniques (8 papers). Dilip Panjwani is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Advanced Radiotherapy Techniques (8 papers). Dilip Panjwani collaborates with scholars based in Canada, Kuwait and United Kingdom. Dilip Panjwani's co-authors include Hilary Blacklock, Paul Griffiths, Mog Ball, H. G. Prentice, Mary Ganczakowski, A. V. Hoffbrand, H. G. Prentice, Kamal Ivory, J. Patterson and M. J. M. L. Gilmore and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Dilip Panjwani

18 papers receiving 581 citations

Peers

Countries citing papers authored by Dilip Panjwani

Since Specialization

Citations

This map shows the geographic impact of Dilip Panjwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilip Panjwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilip Panjwani more than expected).

Fields of papers citing papers by Dilip Panjwani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilip Panjwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilip Panjwani. The network helps show where Dilip Panjwani may publish in the future.

Co-authorship network of co-authors of Dilip Panjwani

This figure shows the co-authorship network connecting the top 25 collaborators of Dilip Panjwani. A scholar is included among the top collaborators of Dilip Panjwani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilip Panjwani. Dilip Panjwani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Palliative sedation at the end of life: Practical and ethical considerations 2025 ·Clinical Medicine ·(unknown), (unknown), (unknown), Dilip Panjwani	0
2	Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Wee Loon Ong, Harvey Quon, Patrick Cheung, William Chu, Hans T. Chung, (unknown), Dilip Panjwani, Yasir Alayed, Geordi Pang, Renée Korol, Libo Zhang, Alexandre Mamedov, Andrea Deabreu, (unknown)	2
3	Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT) 2020 ·Radiotherapy and Oncology ·Yasir Alayed, Harvey Quon, (unknown), Patrick Cheung, William Chu, Hans T. Chung, Danny Vesprini, (unknown), Dilip Panjwani, Geordi Pang, Renée Korol, Melanie Davidson, Ananth Ravi, Boyd McCurdy, Liying Zhang, Alexandre Mamedov, Andrea Deabreu, Andrew Loblaw	25
4	Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials 2019 ·Clinical Oncology ·Soumyajit Roy, Andrew Loblaw, Patrick Cheung, William Chu, Hans T. Chung, Danny Vesprini, (unknown), Amrita Roy Chowdhury, Dilip Panjwani, Geordi Pang, (unknown), Melanie Davidson, Ananth Ravi, Boyd McCurdy, Joelle Helou, Liang Zhang, Alexandre Mamedov, Andrea Deabreu, Harvey Quon	4
5	Accelerating Prostate Stereotactic Ablative Body Radiotherapy (SABR): Efficacy and Toxicity of a Randomized Phase II Study of 11 Versus 29 Days Overall Treatment Time (PATRIOT Study; ClinicalTrials.gov NCT01423474) 2019 ·International Journal of Radiation OncologyBiologyPhysics ·D.A. Loblaw, Harvey Quon, (unknown), Yasir Alayed, Patrick Cheung, William Chu, Hans T. Chung, Danny Vesprini, Amrita Roy Chowdhury, Dilip Panjwani, Geordi Pang, (unknown), Melanie Davidson, Ananth Ravi, Boyd McCurdy, Liping Zhang, Alexandre Mamedov, Andrea Deabreu	3
6	Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial 2018 ·Radiotherapy and Oncology ·Harvey Quon, (unknown), Patrick Cheung, William Chu, Hans T. Chung, Danny Vesprini, (unknown), Dilip Panjwani, Geordi Pang, Renée Korol, Melanie Davidson, Ananth Ravi, Boyd McCurdy, Liying Zhang, Alexandre Mamedov, Andrea Deabreu, Andrew Loblaw	49
7	Phase II Trial of Pure Hypofractionated Radiotherapy in the Treatment of Localized Carcinoma of the Prostate 2018 ·Cureus ·Darin Gopaul, Dilip Panjwani, Robert F. Stephens, Michael Lock	2
8	PATRIOT Trial: Randomized phase II study of prostate stereotactic body radiotherapy comparing 11 versus 29 days overall treatment time. 2015 ·Journal of Clinical Oncology ·Harvey Quon, (unknown), Patrick Cheung, William Chu, Hans T. Chung, Danny Vesprini, (unknown), Dilip Panjwani, Geordi Pang, Renée Korol, Melanie Davidson, Ananth Ravi, Boyd McCurdy, Liying Zhang, Oliver Bucher, Alexandre Mamedov, Andrea Deabreu, (unknown), D.A. Loblaw	9
9	PATRIOT Trial: Randomized Phase 2 Study of Prostate Stereotactic Body Radiation Therapy Comparing 11 Versus 29 Days Overall Treatment Time 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Harvey Quon, (unknown), Patrick Cheung, William Chu, Hans T. Chung, Danny Vesprini, Anirban Chowdhury, Dilip Panjwani, Geordi Pang, (unknown), Melanie Davidson, Ananth Ravi, Boyd McCurdy, Liying Zhang, Oliver Bucher, Alexandre Mamedov, Andrea Deabreu, (unknown), D.A. Loblaw	3
10	Evaluation of an informational pamphlet on distress and perceptions of supportive care for men with prostate cancer 2012 ·Journal of Men s Health ·Michèle Preyde, (unknown), Craig A. Cunningham, Dilip Panjwani	2
11	Evaluation of daily online set-up errors and organ displacement uncertainty during conformal radiation treatment of the prostate 2008 ·British Journal of Radiology ·Ernest Osei, Ran Jiang, Rebecca Barnett, (unknown), Dilip Panjwani	22
12	Post‐renal transplant erythrocytosis: Existence of two distinct types 1990 ·Clinical Transplantation ·Dilip Panjwani, (unknown), Arthur G. White, M. S. A. Kumar, (unknown), (unknown), (unknown)	1
13	Bone Marrow Transplantation for Beta-Thalassaemia major 1989 ·Medical Principles and Practice ·Dilip Panjwani, (unknown), Arthur G. White, (unknown), (unknown), G. M. Abouna	3
14	The living unrelated donor--a viable alternative for renal transplantation. 1988 ·PubMed ·(unknown), Dilip Panjwani, (unknown), (unknown), (unknown), (unknown), M Samhan	7
15	The use of HLA-mismatched living related donors for renal transplantation is justified by the highly successful long-term results. 1988 ·PubMed ·M Samhan, (unknown), (unknown), (unknown), (unknown), Dilip Panjwani, (unknown), (unknown)	3
16	Virological and serological diagnosis of cytomegalovirus infection in bone marrow allograft recipients 1985 ·Journal of Medical Virology ·Dilip Panjwani, Mog Ball, Neil Berry, J. Z. Wimperis, Hilary Blacklock, H. G. Prentice, A. V. Hoffbrand, Paul Griffiths	33
17	RAPID DIAGNOSIS OF CYTOMEGALOVIRUS INFECTION IN IMMUNOCOMPROMISED PATIENTS BY DETECTION OF EARLY ANTIGEN FLUORESCENT FOCI 1984 ·The Lancet ·Paul Griffiths, (unknown), Mary Ganczakowski, Dilip Panjwani, Mog Ball, Hilary Blacklock, H. G. Prentice	178
18	DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS 1984 ·The Lancet ·H. G. Prentice, George Janossy, (unknown), L K Trejdosiewicz, Dilip Panjwani, Stelios Graphakos, Kamal Ivory, Hilary Blacklock, M. J. M. L. Gilmore, N Tidman, D. Skeggs, Sarah E. Ball, J. Patterson, A. V. Hoffbrand	277
19	Electrophysiologic Abnormalities of Heart in Iron Deficiency Anemia 1983 ·Acta Haematologica ·(unknown), Dilip Panjwani, (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact